Jude Onyia insider trades

Open-market stock purchases and sales by Jude Onyia, Chief Scientific Officer at Neurocrine Biosciences Inc, from SEC Form 4 filings since Nov 29, 2021.

Recent trades

DateStockTradeValue
Sep 11, 2026NBIX Neurocrine Biosciences IncBought (not open market)—
Sep 11, 2026NBIX Neurocrine Biosciences IncSold (not open market)$302K
Aug 4, 2026NBIX Neurocrine Biosciences IncSold (not open market)—
Jun 9, 2026VYGR Voyager Therapeutics, IncBought (not open market)—
Jun 5, 2026NBIX Neurocrine Biosciences IncSold (not open market)—
Jun 1, 2026NBIX Neurocrine Biosciences IncSold$1.8M
Jun 1, 2026NBIX Neurocrine Biosciences IncBought (not open market)—
May 27, 2026NBIX Neurocrine Biosciences IncSold$1.7M
May 27, 2026NBIX Neurocrine Biosciences IncBought (not open market)—
Feb 20, 2026NBIX Neurocrine Biosciences IncSold (not open market)—
Feb 13, 2026NBIX Neurocrine Biosciences IncBought (not open market)—
Feb 13, 2026NBIX Neurocrine Biosciences IncSold (not open market)$180K
Feb 13, 2026NBIX Neurocrine Biosciences IncSold (not open market)$182K
Feb 13, 2026NBIX Neurocrine Biosciences IncBought (not open market)—
Feb 13, 2026NBIX Neurocrine Biosciences IncSold (not open market)$1.3M
Feb 13, 2026NBIX Neurocrine Biosciences IncBought (not open market)—
Feb 13, 2026NBIX Neurocrine Biosciences IncBought (not open market)—
Feb 13, 2026NBIX Neurocrine Biosciences IncBought (not open market)—
Feb 12, 2026NBIX Neurocrine Biosciences IncSold (not open market)$176K
Feb 12, 2026NBIX Neurocrine Biosciences IncBought (not open market)—
Jan 31, 2026NBIX Neurocrine Biosciences IncSold (not open market)$19.3K
Jan 31, 2026NBIX Neurocrine Biosciences IncBought (not open market)—
Nov 29, 2025NBIX Neurocrine Biosciences IncSold (not open market)$342K
Nov 29, 2025NBIX Neurocrine Biosciences IncBought (not open market)—

Companies traded

  • NBIX Neurocrine Biosciences Inc: 15 sales, last Sep 11, 2026
  • VYGR Voyager Therapeutics, Inc: other filings, last Jun 9, 2026

Get free alerts when Jude Onyia files a new trade →